A Phase II Efficacy Study of Intracerebral CTX0E03 DP in Patients With Stable Paresis of the Arm Following an Ischaemic Stroke.

Trial Profile

A Phase II Efficacy Study of Intracerebral CTX0E03 DP in Patients With Stable Paresis of the Arm Following an Ischaemic Stroke.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2017

At a glance

  • Drugs ReN 001 (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms PISCES II
  • Sponsors ReNeuron
  • Most Recent Events

    • 29 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Sep 2017.
    • 13 Sep 2016 Status changed from recruiting to active, no longer recruiting.
    • 21 Jun 2016 Planned number of patients changed from 41 to 21.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top